Back to Search Start Over

CABOZANTINIB IS EFFECTIVE IN A SUBSET OF XENOGRAFT GBM TUMORS AND AFFECTS MULTIPLE SIGNALING PATHWAYS.

Authors :
Mikkelsen, Tom
deCarvalho, Ana C.
Arnold, Kimberly
Mueller, Claudius
Petricoin, Emanuel F
Poisson, Laila M.
Irtenkauf, Susan
Hasselbach, Laura
Source :
Neuro-Oncology; Jul2014 Supplement, Vol. 16 Issue suppl_3, piii38-iii38, 1p
Publication Year :
2014

Details

Language :
English
ISSN :
15228517
Volume :
16
Issue :
suppl_3
Database :
Complementary Index
Journal :
Neuro-Oncology
Publication Type :
Academic Journal
Accession number :
97675808
Full Text :
https://doi.org/10.1093/neuonc/nou208.58